ArticleCancer medicine2021

Reducing tumor invasiveness by ramucirumab and TGF-β receptor kinase inhibitor in a diffuse-type gastric cancer patient-derived cell model.

Song-Yi Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.